In TRIUMPH-1, people on the top 12 mg dose lost an average of 28.3% of their body weight over 80 weeks if they stayed on treatment, and 25.0%, including everyone who started
Thyroid concerns are a real, appropriate topic for your prescriber
Because liraglutide shares 97% homology with GLP-1 while exenatide only shares 50% of GLP-1, it is inferred that liraglutide is more likely to mimic the function of endogenous GLP-1
When patients stop taking it, they may experience what we call Ozempic rebound, when those fat cells could potentially expand again
A U.S.-licensed provider reviews your health information, determines if treatment is appropriate, and monitors your progress remotely
Well-designed trials are necessary to examine whether L-carnitine could be helpful in the management of cramps